Formidable Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$718K Buy
10,003
+7,327
+274% +$654K 0.11% 179
2026
Q1
$212K Sell
2,676
-84
-3% -$6.47K 0.03% 361
2025
Q4
$208K Sell
2,760
-335
-11% -$26.4K 0.03% 378
2025
Q3
$214K Sell
3,095
-1,423
-31% -$97.5K 0.03% 372
2025
Q2
$306K Hold
4,518
0.05% 307
2025
Q1
$306K Sell
4,518
-938
-17% -$56.1K 0.05% 307
2024
Q4
$245K Sell
5,456
-1,584
-23% -$88.9K 0.04% 329
2024
Q3
$443K Sell
7,040
-1,984
-22% -$116K 0.07% 242
2024
Q2
$533K Sell
9,024
-1,578
-15% -$98.7K 0.09% 223
2024
Q1
$846K Buy
10,602
+1,807
+21% +$138K 0.14% 151
2023
Q4
$694K Sell
8,795
-653
-7% -$46.5K 0.14% 139
2023
Q3
$660K Buy
9,448
+956
+11% +$67.7K 0.15% 146
2023
Q2
$587K Sell
8,492
-428
-5% -$30.5K 0.13% 153
2023
Q1
$675K Sell
8,920
-182
-2% -$15.3K 0.14% 143
2022
Q4
$848K Sell
9,102
-165
-2% -$15.9K 0.19% 100
2022
Q3
$856K Sell
9,267
-137
-1% -$13.6K 0.2% 95
2022
Q2
$877K Sell
9,404
-24
-0.3% -$2.34K 0.2% 97
2022
Q1
$954K Sell
9,428
-85
-0.9% -$8.93K 0.18% 106
2021
Q4
$989K Sell
9,513
-522
-5% -$48.2K 0.19% 104
2021
Q3
$852K Sell
10,035
-1,264
-11% -$106K 0.16% 120
2021
Q2
$927K Sell
11,299
-2,019
-15% -$165K 0.2% 102
2021
Q1
$994K Sell
13,318
-764
-5% -$55.6K 0.22% 106
2020
Q4
$982K Sell
14,082
-3,685
-21% -$240K 0.23% 94
2020
Q3
$1.03M Buy
17,767
+1,506
+9% +$93.7K 0.3% 78
2020
Q2
$1.05M Sell
16,261
-1,715
-10% -$108K 0.31% 75
2020
Q1
$1.07M Sell
17,976
-1,270
-7% -$84.8K 0.42% 55
2019
Q4
$1.44M Buy
+19,246
New +$1.35M 0.45% 55
2019
Q3
Sell
-17,951
Closed -$1M 145
2019
Q2
$1M Buy
17,951
+10,197
+132% +$549K 0.34% 74
2019
Q1
$1.68M Sell
7,754
-7,481
-49% -$462K 0.66% 29
2018
Q4
$998K Sell
15,235
-83
-0.5% -$6.2K 0.53% 47
2018
Q3
$1.22M Buy
15,318
+215
+1% +$15.4K 0.48% 47
2018
Q2
$972K Buy
15,103
+13
+0.1% +$857 0.42% 53
2018
Q1
$939K Buy
15,090
+424
+3% +$30.4K 0.47% 45
2017
Q4
$1.06M Buy
14,666
+13,156
+871% +$956K 0.49% 47
2017
Q3
$1.12M Sell
1,510
-12,154
-89% -$961K 0.47% 38
2017
Q2
$1.1M Sell
13,664
-552
-4% -$43.6K 0.54% 32
2017
Q1
$1.15M Sell
14,216
-392
-3% -$31.3K 0.5% 37
2016
Q4
$1.15M Buy
14,608
+5,105
+54% +$413K 0.58% 35
2016
Q3
$846K Buy
9,503
+388
+4% +$36.6K 0.42% 45
2016
Q2
$884K Buy
9,115
+1,785
+24% +$178K 0.49% 40
2016
Q1
$747K Buy
7,330
+6,260
+585% +$609K 0.53% 38
2015
Q4
$102K Hold
1,070
0.07% 167
2015
Q3
$103K Hold
1,070
0.07% 170
2015
Q2
$112K Hold
1,070
0.07% 157
2015
Q1
$107K Hold
1,070
0.07% 153
2014
Q4
$103K Hold
1,070
0.07% 143
2014
Q3
$92K Buy
1,070
+62
+6% +$4.89K 0.06% 149
2014
Q2
$76K Buy
1,008
+15
+2% +$1.13K 0.05% 182
2014
Q1
$73K Buy
993
+160
+19% +$11.3K 0.05% 163
2013
Q4
$55K Hold
833
0.04% 187
2013
Q3
$48K Buy
+833
New +$49.6K 0.04% 173

Other funds holding CVS

Formidable Asset Management's CVS Position: Q2 2026 in Review

Formidable Asset Management increased its CVS Health (CVS) stake by 274% in Q2 2026, buying an estimated $654K and bringing the position to 10,003 shares worth $718K. The position accounts for 0.11% of the portfolio, ranked #179.

Formidable Asset Management first reported a position in CVS in Q3 2013 and has held it in 51 quarters since. The position peaked at $1.68M in Q1 2019. 881 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Formidable Asset Management held 10,003 shares of CVS Health worth $718K as of Q2 2026.
  • Formidable Asset Management bought 7,327 CVS Health shares in Q2 2026, an estimated $654K.
  • CVS Health made up 0.11% of Formidable Asset Management's portfolio in Q2 2026, its #179 holding.
  • Formidable Asset Management first reported a position in CVS Health in Q3 2013 and has held it in 51 quarters since.
  • Formidable Asset Management's CVS Health position peaked at $1.68M in Q1 2019.
  • 881 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Formidable Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.